P. Deltenre and P. Mathurin, Épidémiologie de la maladie alcoolique et nouveaux enjeux, 2009.

U. Becker, A. Deis, T. I. Sørensen, M. Grønbaek, K. Borch-johnsen et al., Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study, Hepatology, vol.23, pp.1025-1034, 1996.

S. Bellentani, G. Saccoccio, G. Costa, C. Tiribelli, F. Manenti et al., Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group, Gut, vol.41, pp.845-50, 1997.

, An International Group. Alcoholir Liver Disease: Morphological Manifestations. The Lancet, vol.317, pp.707-718, 1981.

W. C. Maddrey, Alcoholic hepatitis: clinicopathologic features and therapy, Semin Liver Dis, vol.8, pp.91-102, 1988.

P. Mathurin, F. Beuzin, A. Louvet, N. Carrié-ganne, A. Balian et al., Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features, Aliment Pharmacol Ther, vol.25, pp.1047-54, 2007.

J. P. Daures, P. Peray, P. Bories, P. Blanc, A. Yousfi et al., Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis, Gastroenterol Clin Biol, vol.15, pp.223-231, 1991.

W. C. Maddrey, J. K. Boitnott, M. S. Bedine, F. L. Weber, E. Mezey et al., Corticosteroid therapy of alcoholic hepatitis, Gastroenterology, vol.75, pp.193-202, 1978.

R. L. Carithers, H. F. Herlong, A. M. Diehl, E. W. Shaw, B. Combes et al., Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial, Ann Intern Med, vol.110, pp.685-90, 1989.

P. Mathurin, Corticosteroids for alcoholic hepatitis-what's next?, Journal of Hepatology, vol.43, pp.526-559, 2005.

R. S. O'shea, S. Dasarathy, and A. J. Mccullough, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease, Hepatology, vol.51, pp.307-335, 2010.

P. Mathurin, C. L. Mendenhall, R. L. Carithers, M. Ramond, W. C. Maddrey et al., Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH, J Hepatol, vol.36, pp.480-487, 2002.

E. Nguyen-khac, T. Thevenot, M. Piquet, S. Benferhat, O. Goria et al., Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis, N Engl J Med, vol.365, pp.1781-1790, 2011.

E. H. Forrest, C. Evans, S. Stewart, M. Phillips, Y. H. Oo et al., Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score, Gut, vol.54, pp.1174-1183, 2005.

M. Dominguez, D. Rincón, J. G. Abraldes, R. Miquel, J. Colmenero et al., A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, vol.103, pp.2747-56, 2008.

E. Cholongitas, G. V. Papatheodoridis, M. Vangeli, N. Terreni, D. Patch et al., Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, Aliment Pharmacol Ther, vol.22, pp.1079-89, 2005.

R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim et al., Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, vol.124, pp.91-97, 2003.

W. Dunn, L. H. Jamil, L. S. Brown, R. H. Wiesner, W. R. Kim et al., MELD accurately predicts mortality in patients with alcoholic hepatitis, Hepatology, vol.41, pp.353-361, 2005.

W. Srikureja, N. L. Kyulo, B. A. Runyon, and K. Hu, MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis, J Hepatol, vol.42, pp.700-706, 2005.

R. Hamid and E. H. Forrest, Is histology required for the diagnosis of alcoholic hepatitis? a review of published randomised controlled trials, Gut, vol.60, pp.233-233, 2011.

, Management of Alcohol-Related Liver Disease

. Easl-the-home-of-hepatology and . Disponible,

J. Altamirano, R. Miquel, A. Katoonizadeh, J. G. Abraldes, A. Duarte-rojo et al., A histologic scoring system for prognosis of patients with alcoholic hepatitis, Gastroenterology, vol.146, pp.1-6, 2014.

E. Nguyen-khac, J. Cadranel, B. Goichot, J. Denis, J. Bronowicki et al., 1152 Severe Acute alcoholic hepatitis (AAH) in France in 2008: Nationwide survey results (AFEF, ANGH, SNFMI), Journal of Hepatology, vol.52, p.445, 2010.

L. Corvec, M. Jezequel, C. Monbet, V. Fatih, N. Charpentier et al., Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis, PLoS ONE, vol.12, p.185997, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01625051

M. G. Inc, Mid-Infrared spectroscoy has a high sensitivity and specificity by Dr, Rodolphe Anty. Disponible sur

C. G. Child and J. G. Turcotte, Surgery and portal hypertension, Major Probl Clin Surg, vol.1, pp.1-85, 1964.

A. Louvet, S. Naveau, M. Abdelnour, M. Ramond, E. Diaz et al., The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids, Hepatology, vol.45, pp.1348-54, 2007.

E. R. Delong, D. M. Delong, and D. L. Clarke-pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, vol.44, pp.837-882, 1988.

D. Thabut, S. Naveau, C. F. Massard, J. Ratziu, V. Imbert-bismut et al., The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease, J Hepatol, vol.44, pp.1175-85, 2006.

M. Rudler, S. Mouri, C. F. Cluzel, P. Ngo, Y. Munteanu et al., Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis, PLoS ONE, vol.10, p.134302, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01225004

L. Castera, D. J. Hartmann, F. Chapel, C. Guettier, F. Mall et al., Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis, J Hepatol, vol.32, pp.412-420, 2000.

N. G. Ladep, A. C. Dona, M. R. Lewis, M. Crossey, M. Lemoine et al., Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans, Hepatology, vol.60, pp.1291-301, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-02875319

S. Qi, Z. Tu, W. Peng, L. Wang, X. Ou-yang et al., 1 H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis, World J Gastroenterol, vol.18, pp.285-90, 2012.

M. Mcphail, D. L. Shawcross, M. R. Lewis, I. Coltart, E. J. Want et al., Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis, J Hepatol, vol.64, pp.1058-67, 2016.

V. Saxena, A. Gupta, N. Gowda, G. A. Saxena, R. Yachha et al., 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure, NMR Biomed, vol.19, pp.521-527, 2006.